Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
4.005 EUR | -25.28% | -21.57% | -52.10% |
2023 | Biosynex: merger with Theradiag completed | CF |
2023 | Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2021 | 383M 410M | Sales 2022 | 197M 211M | Capitalization | 141M 151M |
---|---|---|---|---|---|
Net income 2021 | 104M 112M | Net income 2022 | 15M 16.09M | EV / Sales 2021 | 0.5 x |
Net cash position 2021 | 96.72M 104M | Net cash position 2022 | 35.09M 37.65M | EV / Sales 2022 | 0.54 x |
P/E ratio 2021 |
2.63
x | P/E ratio 2022 |
9.08
x | Employees | 551 |
Yield 2021 |
7.6% | Yield 2022 |
-
| Free-Float | 39.43% |
1 day | -21.74% | ||
1 week | -17.75% | ||
Current month | -12.88% | ||
1 month | -10.93% | ||
3 months | -48.21% | ||
6 months | -52.71% | ||
Current year | -49.76% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Lamy
FOU | Founder | - | 05-03-14 |
Larry Abensur
CEO | Chief Executive Officer | 69 | 05-03-14 |
Thierry Paper
FOU | Founder | 60 | 05-03-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thierry Paper
FOU | Founder | 60 | 05-03-14 |
Thomas Lamy
FOU | Founder | - | 05-03-14 |
Larry Abensur
CEO | Chief Executive Officer | 69 | 05-03-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 4.005 | -25.28% | 62 528 |
24-04-24 | 5.36 | +1.13% | 5,754 |
24-04-23 | 5.3 | +0.76% | 10,618 |
24-04-22 | 5.26 | +3.14% | 6,526 |
24-04-19 | 5.1 | 0.00% | 5,290 |
Real-time Euronext Paris, April 25, 2024 at 04:54 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-49.76% | 61.64M | |
-11.57% | 7.5B | |
+1.67% | 5.48B | |
+0.98% | 4.61B | |
+5.18% | 4.47B | |
-50.82% | 3.28B | |
+11.23% | 2.71B | |
-15.25% | 2.02B | |
-2.66% | 1.69B | |
-10.84% | 1.74B |
- Stock Market
- Equities
- ALBIO Stock